6.9 ANTIPLATELET AND VASCULAR EFFECTS OF ASPIRIN IN HEALTHY PERSONS AND PATIENTS WITH TYPE 2 DIABETES
Background: Treatment with aspirin is a cornerstone in the secondary prevention of cardiovascular disease (CVD) in diabetes, whereas its place in primary prevention remains controversial. The effect of once-daily aspirin on platelet aggregation is unclear in patients with diabetes. Furthermore, the...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Atlantis Press
2016-11-01
|
| Series: | Artery Research |
| Online Access: | https://www.atlantis-press.com/article/125930426/view |